Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data.

Jenny E Blau Sri Harsha Tella Simeon I Taylor Kristina I Rother

Published in: Diabetes/metabolism research and reviews (2017)

Our results support the FDA's warning that SGLT2 inhibitors lead to ketoacidosis, as evidenced by an increased reporting rate for acidosis above that in a comparator population treated with DPP4 inhibitors.

Keyphrases

electronic health record
emergency department
combination therapy
newly diagnosed
replacement therapy